Pharmacotherapy of type 2 diabetes mellitus.
Rendell, M S
Pharmacotherapy of type 2 diabetes mellitus. [electronic resource] - The Annals of pharmacotherapy - 878-95 p. digital
Publication Type: Journal Article; Review
1060-0280
10.1345/aph.19171 doi
Anti-Obesity Agents--therapeutic use
Biguanides--adverse effects
Chromans--therapeutic use
Chromium Compounds--administration & dosage
Complementary Therapies
Diabetes Mellitus, Type 2--drug therapy
Diet Therapy
Disaccharidases--antagonists & inhibitors
Humans
Hypoglycemic Agents--therapeutic use
Insulin--metabolism
Leptin--therapeutic use
Sulfonylurea Compounds--therapeutic use
Thiazoles--therapeutic use
Thiazolidinediones
Troglitazone
United Kingdom
Vanadium Compounds--adverse effects
Pharmacotherapy of type 2 diabetes mellitus. [electronic resource] - The Annals of pharmacotherapy - 878-95 p. digital
Publication Type: Journal Article; Review
1060-0280
10.1345/aph.19171 doi
Anti-Obesity Agents--therapeutic use
Biguanides--adverse effects
Chromans--therapeutic use
Chromium Compounds--administration & dosage
Complementary Therapies
Diabetes Mellitus, Type 2--drug therapy
Diet Therapy
Disaccharidases--antagonists & inhibitors
Humans
Hypoglycemic Agents--therapeutic use
Insulin--metabolism
Leptin--therapeutic use
Sulfonylurea Compounds--therapeutic use
Thiazoles--therapeutic use
Thiazolidinediones
Troglitazone
United Kingdom
Vanadium Compounds--adverse effects